Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2018-03-26

FDA Approved: ASMANEX — Supplemental Application (Organon LLC)

View source ↗

Summary

The FDA approved a supplemental application for ASMANEX (mometasone furoate) from Organon LLC, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASMANEX (MOMETASONE FUROATE)

Snippet

SUPPL AP for ASMANEX (MOMETASONE FUROATE)